Neoplasm by Morphology — Trials

Neoplasm by Morphology — Trials · CancerIndex

Clinical trials

Registered studies

52,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 401–450 of 1,995 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06400264	Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)	withdrawn	Phase 2	0	National Cancer Institute (NCI)NIH	0	May 6, 2024	clinicaltrials
NCT05807126	Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations	withdrawn	Phase 1	0	National Cancer Institute (NCI)NIH